207_Combined course Presentations

Additional Evaluations :

 Adequate pulmonary function tests (PFTs) and cardiac function, results from laboratory tests are normal



Brain MRI: Negative

 Molecular Analysis (biopsy of the Lung Tumor): EGFR mutation (deletion 19)

Clinical Stage: T2bN2M0 (IIIA-N2)

Patient was presented and discussed at a multidisciplinary thoracic tumor board